Rosetta Omics

Paris, France

Rosetta Omics is a healthcare startup focused on precision medicine, particularly in oncology. The company utilizes high-resolution mass spectrometry profiling and advanced AI techniques to provide tumor characterization and improve cancer patient treatment outcomes. Its services include integrated diagnostics that assist in the decision-making process for oncologists, clinicians, and pathologists, allowing for better diagnosis, stratification, and ranking of first-line treatment options. Among its innovations are methodologies such as mass spectrometry imaging (MSI) and liquid chromatography coupled tandem mass spectrometry (LC-MS/MS) for high-resolution peptide identification. Rosetta Omics also aims to identify biomarkers for drug development and improve treatment response predictions using AI-driven algorithms, thereby enhancing patient care management and offering personalized treatment strategies.